Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Contemporary Clinical Trials|July 11, 2006
Endpoints for agents that slow tumor growthRon X Yu, Eric HolmgrenStatistics in Medicine|July 12, 2008
Quantifying the usefulness of PD biomarkers in Phase 2 screening trials of oncology drugsEric HolmgrenContemporary Clinical Trials|March 2, 2017
The application of group sequential stopping boundaries to evaluate the treatment effect of an experimental agent across a range of biomarker expressionEric HolmgrenContemporary Clinical Trials|April 7, 2007
An adaptive Simon Two-Stage Design for Phase 2 studies of targeted therapiesCheryl L Jones, Eric HolmgrenPlos One|March 20, 2008
Identification of direct target genes using joint sequence and expression likelihood with application to DAF-16Ron X Yu, Jie Liu, Nick True, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|October 17, 2020
Penetrating Midface Trauma: A Case Report, Review of the Literature, and a Diagnostic and Management ProtocolEric Holmgren, Derrek Schartz, Nithya Puttige Ramesh, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|October 26, 2005
Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic gradeDeepak Kademani, R Bryan Bell, Shahrokh Bagheri, et al.Genes, Chromosomes & Cancer|December 31, 2005
Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian cancer cell linesYan C Wang, Dejan Juric, Brian Francisco, et al.The Oncologist|September 9, 2008
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancerFairooz F Kabbinavar, Joel F Wallace, Eric Holmgren, et al.Pageof 3